News Hexima Limited

Equities

Market Closed - Australian S.E. Other stock markets 11:40:10 22/04/2024 am IST			5-day change	1st Jan Change
0.013 ^AUD	0.00%		0.00%	-27.78%

22/03	Hexima Secures R&D Tax Rebate for Fiscal Year 2023	MT
19/03	Hexima Changes Address	MT

Hexima Secures R&D Tax Rebate for Fiscal Year 2023	22/03	MT
Hexima Changes Address	19/03	MT
Hexima Limited Announces Change of Address	19/03	CI
Hexima Limited Reports Earnings Results for the Half Year Ended December 31, 2023	29/02	CI
Hexima Limited Announces the Resignation of Dr. Nicole Van Der Weerden as Director	29/11	CI
Hexima Limited Appoints Phillip Hains as A Non-Executive Director	19/23/19	CI
Hexima Limited Appoints Geoffrey Kempler as Managing Director	06/23/06	CI
Hexima Limited Announces Executive Changes	06/23/06	CI
Hexima Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/23/31	CI
Hexima Limited Announces Resignation of Mr. Steven Skala as an Alternate Director	11/23/11	CI
Hexima Limited Reports Earnings Results for the Half Year Ended December 31, 2022	28/23/28	CI
Hexima Limited Declares Voting Results	31/23/31	CI
Arovella Therapeutics Appoints COO	04/23/04	MT
Hexima Acting CEO to Step Down	22/22/22	MT
Nicole Van Der Weerden to Step Down as CEO of Hexima Limited	22/22/22	CI
Hexima Receives AU$6 Million Tax Incentive Refund from Australian Taxation Office	14/22/14	MT
Hexima Limited Receives Requisition Notice from Merchant Biotech Fund	14/22/14	CI
Hexima Limited Announces Board Changes	05/22/05	CI
10,150,000 Options of Hexima Limited are subject to a Lock-Up Agreement Ending on 1-DEC-2022.	01/22/01	CI
6,925,878 Ordinary Shares of Hexima Limited are subject to a Lock-Up Agreement Ending on 1-DEC-2022.	01/22/01	CI

No results for this search